Enteral and Parenteral Medical Nutrition Market is expected to reach US$ 25,476.86 million by 2028

Elderly Segment to Lead Global Enteral and Parenteral Medical Nutrition Market during 2023–2028

According to our new research study on “Enteral and Parenteral Medical Nutrition Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Indication, Nutrition Type, Form, Product Type, Route of Administration, Age Group, and Distribution Channel,” the market is expected to grow from US$ 17,343.46 million in 2022 to US$ 25,476.86 million by 2028; it is estimated to grow at a CAGR of 6.8% during 2023–2028. The growth of the market is attributed to rise in prevalence of gastrointestinal diseases and increasing cases of malnutrition and premature births.

Based on indication, the enteral and parenteral medical nutrition market is segmented into elderly, gastrointestinal disorder, cancer, diabetes, respiratory disorders, Alzheimer’s disease, dementia, renal disease, liver failure, COVID-19 infection, and others. The elderly segment accounted for the largest enteral and parenteral medical nutrition market share in 2022 and gastrointestinal disorders segment is anticipated to register the highest CAGR of 7.3% during the forecast period. Aging can cause a consistent loss of physiological integrity, resulting in a reduction in functionality and an increased risk of mortality. The degradation of body function is a crucial risk factor for contracting most chronic diseases, including diabetes, CVD, and neurological disorders, among elderly patients. According to the Global Ageing Survey 2019, the frequency of a person aged 65 or above is likely to increase from 1 in every 11 inhabitants in 2019 to 1 in every 6 inhabitants by 2025. Weight loss is commonly observed in the elderly, resulting in poor quality of life, morbidity, and mortality. Hence, appropriate nutritional support is vital for the elderly to control weight loss or malnutrition problems. Enteral nutrition is often preferred over parenteral nutrition for nutritional support for maintaining gut function and immunity. However, it may be challenging to provide enteral nutrition to elderly people with conditions, owing to which parenteral nutrition occasionally becomes an essential alternative for nutritional support. Use of enteral and parenteral medical nutrition administration to provide the necessary nutrients to elderly population is fuelling the enteral and parenteral medical nutrition market growth.

Enteral and Parenteral Medical Nutrition Market, by Region, 2022 (%)

Impact of COVID-19 Pandemic on Enteral and Parenteral Medical Nutrition Market

North American countries are highly equipped with high technological and advanced research industries. The demand for enteral and parenteral medical nutrition increased during the pandemic among severe COVID-19 patients. Evaluating the nutrition status of the COVID-19 infected patients was more important.  According to data published by the American Society of Parenteral and Enteral Nutrition (ASPEN), all recommendations and guidelines available for clinical nutrition in critically ill patients were also applicable to severely ill COVID-19 patients. According to a study published in Nutrients in March 2022, prompt enteral nutrition support and the administration of adequate nutrients were crucial to prevent malnutrition in COVID-19 patients.

In the US, various hospitals administered enteral nutrition to critically ill COVID-19 patients. According to a study titled “Role of Early Enteral Nutrition in Mechanically Ventilated COVID-19 Patients,” conducted in the US, the administration of early enteral nutrition in critically ill patients led to reduced ICU and hospital stays, freedom from mechanical ventilation, and reduced costs of treatments. Initially, COVID-19 patients (including the ones who developed ventilator-dependent chronic respiratory failure) received enteral nutrition through the nasogastric tube. Therefore, there was a significant growth in enteral and parenteral nutrition demand and usage to treat the COVID-19 patients, which in turn positively impacted the enteral and parenteral medical nutrition market growth.

Abbott Laboratories, Nestle SA, Nutricia International BV, Medtrition Inc, Fresenius Kabi AG, B. Braun SE, Smartfish AS, Nutrisens SAS, AYMES International Ltd, Medifood International SA, Easy Line Ltd, Charing Cross Scientific AS, Baxter International Inc, and Medica Nutrition Inc. are among the leading companies operating in the enteral and parenteral medical nutrition market.

The enteral and parenteral medical nutrition market, by indication, is segmented into elderly, gastrointestinal disorder, cancer, diabetes, respiratory disorders, Alzheimer’s disease, dementia, renal disease, liver failure, post COVID-19, and others. The enteral and parenteral medical nutrition market, by nutrition type, is bifurcated into supplemental and sole-source. The enteral and parenteral medical nutrition market, by form, is segmented into liquid, powder, and semi-solid. The enteral and parenteral medical nutrition market, by product type, is bifurcated into general and disease-specific. The enteral and parenteral medical nutrition market, by route of administration, is segmented into oral, tube feed, and parenteral. The enteral and parenteral medical nutrition market, by age group, is segmented into above 60 years, 18–60 years, 3–18 years, and below 3 years. The enteral and parenteral medical nutrition market, by distribution channel, is segmented into hospitals pharmacies, retail stores, e-commerce, and others. By geography, the enteral and parenteral medical nutrition market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com